Pediatric-onset mastocytosis: A long term clinical follow-up and correlation with bone marrow histopathology

Pediatric Blood and Cancer

Volumn 53, Issue 4, 2009, Pages 629-634

  Uzzaman, Ashraf ^a   Maric, Irina ^b   Noel, Pierre ^b   Kettelhut, Brett V ^c   Metcalfe, Dean D ^a   Carter, Melody C ^a,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

Bone marrow; Cutaneous mastocytosis; KIT; Pediatric mastocytosis; Serum tryptase; Urticaria pigmentosa

Indexed keywords

ADULT; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; MASTOCYTOSIS; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REPEAT PROCEDURE; SYSTEMIC DISEASE; BLOOD; BONE MARROW; BONE MARROW EXAMINATION; CHILD; INFANT; PATHOLOGY; PRESCHOOL CHILD;

TRYPTASE;

BONE MARROW; BONE MARROW EXAMINATION; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MASTOCYTOSIS; TRYPTASES;

EID: 69849091836     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22125     Document Type: Article

References (18)

1. Kettelhut BV, Parker RI, Travis WD, et al. Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients. Am J Clin Pathol 1989;91:558-562. (Pubitemid 19130281)
2. Akoglu G, Erkin G, Cakir B, et al. Cutaneous mastocytosis: Demographic aspects and clinical features of 55 patients. J Eur Acad Dermatol Venereol 2006;20:969-973. (Pubitemid 44241386)
3. Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis: A review of 180 patients. Isr Med Assoc J 2005;7:320-322. (Pubitemid 40668155)
4. Caplan RM. The natural course of urticaria pigmentosa. Analysis and follow-up of 112 cases. Arch Dermatol 1963;87:146-157.
5. Kiszewski AE, Duran-Mckinster C, Orozco-Covarrubias L, et al. Cutaneous mastocytosis in children: A clinical analysis of 71 cases. J Eur Acad Dermatol Venereol 2004;18:285-290. (Pubitemid 38618323)
6. Azana JM, Torrelo A, Mediero IG, et al. Urticaria pigmentosa: A review of 67 pediatric cases. Pediatr Dermatol 1994;11:102-106. (Pubitemid 24174274)
7. Valent PHH, Li CY, Longley BJ, et al., editors. Mastocytosis. Lyon: IARC Press; 2001. p. 291.
8. Valent P, Akin C, Escribano L, et al. Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007;37:435-453. (Pubitemid 46817344)
9. Maric I, Robyn J, Metcalfe DD, et al. KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities. J Allergy Clin Immunol 2007;120:680-687. (Pubitemid 47320757)
10. Parker RI. Hematologic aspects of mastocytosis: II: Management of hematologic disorders in association with systemic mast cell disease. J Invest Dermatol 1991;96:52S-53S, discussion 53S-54S, 60S-65S.
11. Nagata H, Worobec AS, Oh CK, et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995;92:10560-10564.
12. Hoffmann KM, Moser A, Lohse P, et al. Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation. Blood 2008;112:1655-1657.
13. Longley BJ, Jr., Metcalfe DD, Tharp M, et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999;96:1609-1614. (Pubitemid 29098499)
14. Enrique E, Garcia-Ortega P, Sotorra O, et al. Usefulness of UniCAP-Tryptase fluoroimmunoassay in the diagnosis of anaphylaxis. Allergy 1999;54:602-606. (Pubitemid 29301816)
15. Lin RY, Schwartz LB, Curry A, et al. Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study. J Allergy Clin Immunol 2000;106:65-71. (Pubitemid 30482854)
16. Schwartz LB, Metcalfe DD, Miller JS, et al. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987;316:1622-1626.
17. Schwartz LB, Sakai K, Bradford TR, et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995;96:2702-2710.
18. Brockow K, Scott LM, Worobec AS, et al. Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: Correlation with clinical patterns of disease. Arch Dermatol 2002;138:785-790. (Pubitemid 34625523)